ABN Amro Investment Solutions Grows Position in Colgate-Palmolive Company $CL

ABN Amro Investment Solutions raised its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 7.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 140,942 shares of the company’s stock after purchasing an additional 10,264 shares during the quarter. ABN Amro Investment Solutions’ holdings in Colgate-Palmolive were worth $12,012,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. HighPoint Advisor Group LLC grew its stake in shares of Colgate-Palmolive by 0.7% during the 4th quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock valued at $1,255,000 after buying an additional 109 shares during the period. Clear Harbor Asset Management LLC grew its stake in shares of Colgate-Palmolive by 2.6% in the fourth quarter. Clear Harbor Asset Management LLC now owns 4,503 shares of the company’s stock valued at $356,000 after buying an additional 113 shares in the last quarter. Moneta Group Investment Advisors LLC grew its position in Colgate-Palmolive by 0.7% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 15,506 shares of the company’s stock valued at $1,225,000 after acquiring an additional 114 shares in the last quarter. Sunpointe LLC grew its holdings in Colgate-Palmolive by 4.0% during the 4th quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock valued at $241,000 after purchasing an additional 117 shares in the last quarter. Finally, ANB Bank grew its holdings in Colgate-Palmolive by 1.7% during the 1st quarter. ANB Bank now owns 7,200 shares of the company’s stock valued at $614,000 after purchasing an additional 120 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL opened at $91.69 on Thursday. The stock has a market capitalization of $73.37 billion, a PE ratio of 35.68, a price-to-earnings-growth ratio of 4.77 and a beta of 0.33. The business’s fifty day moving average price is $90.70 and its 200 day moving average price is $88.86. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. During the same period last year, the firm posted $0.91 EPS. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. Equities research analysts forecast that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 82.49%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Bank of America cut their price objective on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a report on Friday, April 10th. UBS Group boosted their price target on Colgate-Palmolive from $100.00 to $106.00 and gave the stock a “buy” rating in a research note on Thursday, July 16th. Citigroup increased their price target on Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Barclays lifted their price objective on Colgate-Palmolive from $80.00 to $87.00 and gave the stock an “equal weight” rating in a report on Tuesday. Finally, Wall Street Zen lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Sunday, March 29th. Twelve investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $97.82.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.